[go: up one dir, main page]

ATE397012T1 - Therapeutische verwendung von verdünnten surfactants zur lungenwaschung - Google Patents

Therapeutische verwendung von verdünnten surfactants zur lungenwaschung

Info

Publication number
ATE397012T1
ATE397012T1 AT98906033T AT98906033T ATE397012T1 AT E397012 T1 ATE397012 T1 AT E397012T1 AT 98906033 T AT98906033 T AT 98906033T AT 98906033 T AT98906033 T AT 98906033T AT E397012 T1 ATE397012 T1 AT E397012T1
Authority
AT
Austria
Prior art keywords
therapeutic use
surfactant
variety
disclosed
molecules
Prior art date
Application number
AT98906033T
Other languages
English (en)
Inventor
Charles Cochrane
Susan Revak
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25303699&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE397012(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Application granted granted Critical
Publication of ATE397012T1 publication Critical patent/ATE397012T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT98906033T 1997-04-28 1998-01-29 Therapeutische verwendung von verdünnten surfactants zur lungenwaschung ATE397012T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/848,580 US6013619A (en) 1988-01-06 1997-04-28 Pulmonary surfactants and therapeutic uses, including pulmonary lavage

Publications (1)

Publication Number Publication Date
ATE397012T1 true ATE397012T1 (de) 2008-06-15

Family

ID=25303699

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98906033T ATE397012T1 (de) 1997-04-28 1998-01-29 Therapeutische verwendung von verdünnten surfactants zur lungenwaschung

Country Status (10)

Country Link
US (1) US6013619A (de)
EP (1) EP1005485B1 (de)
JP (2) JPH10316587A (de)
AT (1) ATE397012T1 (de)
AU (1) AU734991B2 (de)
BR (1) BR9809321A (de)
CA (1) CA2288375C (de)
DE (1) DE69839558D1 (de)
NZ (2) NZ337619A (de)
WO (1) WO1998049191A1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6613734B2 (en) * 1988-01-06 2003-09-02 The Scripps Research Institute Peptides-containing liposomal surfactants
ES2189269T3 (es) * 1997-12-03 2003-07-01 Britannia Pharmaceuticals Ltd Mejoras en medicamentos para el tratamiento del asma.
US20030221199A1 (en) * 1998-10-20 2003-11-27 Whitsett Jeffrey A. Surfactant protein D for the prevention and diagnosis of pulmonary emphysema
US6838428B2 (en) * 1998-10-20 2005-01-04 Children's Hospital Medical Center Surfactant protein D for the prevention and diagnosis of pulmonary emphysema
US8933032B2 (en) 1998-10-20 2015-01-13 Children's Hospital Medical Center Surfactant protein D for the treatment of disorders associated with lung injury
DE19858463A1 (de) * 1998-12-18 2000-06-21 Centeon Pharma Gmbh Verwendung eines Fibrinklebers zur Regeneration des Lebergewebes
WO2000076535A1 (en) * 1999-06-11 2000-12-21 Byk Gulden Lomberg Chemische Fabrik Gmbh Pharmaceutical preparation containing modifications of surfactant protein b (sp-b) and surfactant protein c (sp-c)
US6287290B1 (en) 1999-07-02 2001-09-11 Pulmonx Methods, systems, and kits for lung volume reduction
AU6083899A (en) 1999-09-16 2001-04-17 Aventis Behring Gmbh Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
AU2003201A (en) * 1999-12-01 2001-06-12 Byk Gulden Lomberg Chemische Fabrik Gmbh Novel use of lung surfactant
JP2003530356A (ja) * 2000-04-12 2003-10-14 アルタナ ファルマ アクチエンゲゼルシャフト 急性肺疾患の予防又は早期治療のための肺表面活性物質の新規使用
US6527761B1 (en) 2000-10-27 2003-03-04 Pulmonx, Inc. Methods and devices for obstructing and aspirating lung tissue segments
US20030030542A1 (en) * 2001-08-10 2003-02-13 Von Hoffmann Gerard PDA security system
WO2003022221A2 (en) 2001-09-10 2003-03-20 Pulmonx Method and apparatus for endobronchial diagnosis
EP1435994B1 (de) 2001-10-11 2010-05-19 Nycomed GmbH Neue verwendung von lungensurfactant
WO2003053455A1 (en) * 2001-12-12 2003-07-03 Penn State Research Foundation Surfactant prevention of lung complications from cancer chemotherapy
US7490604B2 (en) * 2002-03-15 2009-02-17 C. R. Bard, Inc. Endotracheal surfactant distribution system
NZ536796A (en) * 2002-04-25 2007-03-30 Scripps Research Inst Treatment and prevention of pulmonary conditions comprising at least one lung surfactant polypeptide and at least one protease inhibitor, lipase inhibitor or an anti-oxidant
RU2005115956A (ru) * 2002-10-25 2006-08-10 Сеймур Дж. КУРТЦ (US) Способ лечения инсулинорезистентности, диабета взрослых и метаболического синдрома х
US20070065433A1 (en) * 2003-02-21 2007-03-22 Mollnes Tom E Methods and compositions for the treatment of meconium aspiration syndrome
AU2004296206A1 (en) * 2003-12-04 2005-06-23 The Scripps Research Institute Treatment and preventions of asthma
US7464012B2 (en) * 2004-12-10 2008-12-09 L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude Simplified process simulator
US8337815B2 (en) * 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
SI1841458T1 (sl) 2005-01-06 2012-04-30 Discovery Lab Inc Zdravljenje s predpisanim odmerjanjem surfaktanta za zdravljenje ali preprečevanje bronhopulmonalne displazije
US8496006B2 (en) 2005-01-20 2013-07-30 Pulmonx Corporation Methods and devices for passive residual lung volume reduction and functional lung volume expansion
US11883029B2 (en) 2005-01-20 2024-01-30 Pulmonx Corporation Methods and devices for passive residual lung volume reduction and functional lung volume expansion
US20080228137A1 (en) 2007-03-12 2008-09-18 Pulmonx Methods and devices for passive residual lung volume reduction and functional lung volume expansion
CA2606688A1 (en) * 2005-05-03 2006-11-09 Ross Allen Ridsdale Phospholipid formulations and uses thereof in lung disease detection and treatment
US20110177996A1 (en) * 2005-05-23 2011-07-21 Children's Hospital Medical Center Regulatory proteins in lung repair and treatment of lung disease
ZA200800255B (en) * 2005-06-24 2009-04-29 Drugrecure Aps Airway administration of activated protein C in inflammatory conditions affecting the respiratory tract
WO2007092939A2 (en) * 2006-02-08 2007-08-16 Morphotek, Inc. Antigenic gm-csf peptides and antibodies to gm-csf
EP2063903A1 (de) * 2006-09-19 2009-06-03 Discovery Laboratories, Inc. Lungentensidformulierungen und verfahren zur förderung von schleimbeseitigung
CN102014924B (zh) 2007-06-21 2012-07-18 潘塔希生物科学股份有限公司 用雌激素治疗胎粪吸入综合征
EP2349420B1 (de) 2008-09-25 2016-08-31 Covidien LP Inversionsbasierte feed-forward-kompensierung der einatmungs-trigger-dynamik in medizinischen beatmungsgeräten
US8434479B2 (en) * 2009-02-27 2013-05-07 Covidien Lp Flow rate compensation for transient thermal response of hot-wire anemometers
US20110213215A1 (en) * 2010-02-26 2011-09-01 Nellcor Puritan Bennett Llc Spontaneous Breathing Trial Manager
US20120220531A1 (en) 2011-02-04 2012-08-30 Cincinnati Children's Hospital Medical Center Surfactant protein d for the treatment of disorders associated with lung injury
US9089657B2 (en) 2011-10-31 2015-07-28 Covidien Lp Methods and systems for gating user initiated increases in oxygen concentration during ventilation
WO2013188016A2 (en) 2012-05-04 2013-12-19 Discovery Laboratories, Inc. Surfactant therapy for exposure to ionizing radiation
WO2014210030A2 (en) * 2013-06-25 2014-12-31 Ino Therapeutics Llc Methods of reducing the risk of mortality associated with a medical treatment
RU2691648C1 (ru) * 2018-05-28 2019-06-17 Олег Александрович Розенберг Способ получения сурфактанта из легких крупного рогатого скота
US20230257446A1 (en) 2020-01-28 2023-08-17 Chiesi Farmaceutici S.P.A. Polypeptides having improved properties
CN114767977B (zh) * 2022-04-18 2023-10-13 广州呼吸健康研究院(广州呼吸疾病研究所) 一种针对离体肺获取的支气管肺泡灌洗液及其获取方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3369644D1 (en) * 1982-11-22 1987-03-12 Teijin Ltd Artificial lung surfactant and remedy for respiratory distress syndrome containing it as active principle
US5260273A (en) * 1988-01-06 1993-11-09 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
US5164369A (en) * 1988-01-06 1992-11-17 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
US4861756A (en) * 1988-03-08 1989-08-29 Merrell Dow Pharmaceuticals Inc. Synthetic pulmonary surfactant
US5562608A (en) * 1989-08-28 1996-10-08 Biopulmonics, Inc. Apparatus for pulmonary delivery of drugs with simultaneous liquid lavage and ventilation
US5803078A (en) * 1994-05-06 1998-09-08 Brauner; Mark E. Methods and apparatus for intrapulmonary therapy and drug administration

Also Published As

Publication number Publication date
US6013619A (en) 2000-01-11
CA2288375C (en) 2002-09-10
EP1005485A1 (de) 2000-06-07
JP2004250459A (ja) 2004-09-09
BR9809321A (pt) 2000-07-04
NZ337619A (en) 2001-08-31
NZ511640A (en) 2005-07-29
DE69839558D1 (de) 2008-07-10
AU734991B2 (en) 2001-06-28
AU6136998A (en) 1998-11-24
WO1998049191A1 (en) 1998-11-05
CA2288375A1 (en) 1998-11-05
EP1005485B1 (de) 2008-05-28
JPH10316587A (ja) 1998-12-02
EP1005485A4 (de) 2004-03-17

Similar Documents

Publication Publication Date Title
DE69839558D1 (de) Therapeutische verwendung von verdünnten surfactants zur lungenwaschung
BR0009964A (pt) Peptìdios artificiais com atividade desuperfìcie e sua utilização na preparação de surfactante artificial
DE3874798D1 (de) Therapeutisches proteinagens in form von aerosol.
HUP9902698A2 (hu) Humán bikunin
DE69625691D1 (de) Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten
TR199902538T2 (xx) Yeni bile�imler.
TR200101307T2 (tr) Antranilik asit amidler ve ilaç olarak kullanılmaları.
ATE437221T1 (de) Lentivirale vektoren kodierend für gerinnungsfaktoren für die gentherapie
ATE265529T1 (de) Bmp-10 zusammensetzungen
ATE66568T1 (de) Sterilisierende zusammensetzungen.
ATE497390T1 (de) Neue therapeutische verwendung von smr-1 peptide
ATE374618T1 (de) Verwendung von rekombinanten menschlichen uteroglobin zur behandlung von fibrotischen krankheitszuständen
EE04055B1 (et) Ühendid ja kompositsioonid seriinproteaasse, eriti trüptaasse aktiivsusega seotud haiguste raviks, ja nende kasutamine
ATE231522T1 (de) Fragmente eines oberflächenaktiven lungenproteins
DE69725457D1 (de) Piperazinderivate als neurokinin-antagonisten
DE69013011D1 (de) Bcrf1-proteine als inhibitoren von interferon-g(g).
ATE513033T1 (de) Expression von proteinen in aus nabelschnurblut gewonnenen endothelzellen
NO975028L (no) Piperazinoderivater som neurokininantagonister
HUP9901161A2 (hu) Módosított aktivitású hibrid VIII. faktor
UA26313A (uk) Засіб для замісhої терапії захворюваhь дихальhих шляхів, переважhо при сиhдромі задухи
DE60120990D1 (de) Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen
ATE510911T1 (de) Prothrombin aktivierendes protein
ATE323505T1 (de) Verwendung von rekombinantem lungensurfactant zur frühbehandlung von akuten lungenerkrankungen
FI980902A0 (fi) Levosimendaanin stabiileja koostumuksia
ATE295838T1 (de) Benzimidazolderivate zur behandlung von mit mikroglia-aktivierung assoziierten erkrankungen wie inflammatorische, allergische, infektiöse oder autoimmune erkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties